Trial intelligence / Profile preview

Melatonin and MTNR1B Genotype on Glucose Control

NCT02642640Completed

Sponsor
Brigham and Women's Hospital
Start
Nov 2016
Primary completion
Mar 2022
Countries
1
01

Overview

Randomised trial (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Disposition Index at Day 4. Started Nov 2016; status: completed.

Beyond the preview

Go deeper on NCT02642640.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02642640.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call